Microbial infections, which are less prevalent in populations with improved lifestyles and better hygiene, may play a protective role in the aetiology of asthma and allergy. 8, 9 Several viral and parasitic pathogens, including influenza viruses and helminths, have been reported to play a role in protection against asthma and allergy. 10, 11 Helicobacter pylori is a common bacterium, which is estimated to be present in the stomach of around half the world's population. It usually colonizes the gastric mucosa from early childhood, where it persists lifelong unless treated with antibiotics. It is the major cause of peptic ulceration and gastric cancer; however, disease occurs in only 10%-15% of cases and the infection usually remains asymptomatic. Helicobacter pylori has co-evolved with humans over thousands of years; however, the prevalence of the infection (particularly amongst children in developed countries) has been declining rapidly over the last two decades. [12] [13] [14] Important epidemiologic evidence for the role of H. pylori in the hygiene hypothesis has recently emerged, and the infection has been associated with a reduced risk of allergic disorders including asthma, 15 wheeze, 16 eczema [17] [18] [19] and atopy. [20] [21] [22] This association has also been reported to be stronger with more pathogenic strains of H. pylori which express the virulence factor cytotoxin-associated gene A (CagA). 23, 24 Infection with these strains reportedly induces a higher-level T-helper 1 (Th1) cellular immune response, 24, 25 which may counterbalance the pro-allergic Th2 response. CagA+ strains usually also co-express the most active form of the vacuolating cytotoxin A (VacA), and this is important in the induction of immunosuppressive regulatory T cell (Treg) responses. 26 Higher frequencies of IL-10-secreting Tregs were shown to be present in the peripheral blood of H. pylori-infected patients in the UK, and serum IgE concentrations were lowest when there was a strong Treg response. Mechanistic in vitro experiments showed that the systemic IL-10+ Treg response is likely to play an important role in H. pylori-mediated protection against allergy in humans. 26 A number of studies with mouse models of allergy and asthma have very convincingly demonstrated that H. pylori infection is protective and that VacA-induced Tregs play a major role. [27] [28] [29] Despite this convincing evidence, however, others have reported no epidemiological association between the infection and asthma 30, 31 or atopy. 31, 32 This inconsistency may be attributed to the way in which allergic disease is defined or the heterogeneity of the study designs and study populations.
Our recent meta-analysis, using 16 observational studies showed a significant protective effect of H. pylori infection against objectively measured atopy. 33 However, most studies included in this analysis were cross-sectional, with only two prospective studies, 34, 35 based in adult high-income country populations, and lacked data on children from low-income countries. This is important as infection with H. pylori is usually acquired very early in childhood, 36 1065 were recruited (86% of those eligible), and all live singleton babies born to these women (n = 1006) were followed up as a birth cohort ( Figure 1 ).
| Measurement and data collection
At age 6.5 follow-ups visits took place, where the same project data collectors visited the child at home and collected information related to allergic outcomes. Questions on allergic disease symptoms were based on the International Study of Asthma and Allergies in Children (ISAAC) core allergy and environmental questionnaire, 44 and included wheeze ("In the last 12 months has your child had wheezing or whistling in their chest?"), asthma ("In the last 12 months has your child had asthma?"), hayfever ("In the last 12 months has your child had problems with sneezing or running nose (when not affected by cold or flu), or problems with itchy watery eyes?") and eczema ("In the last 12 months has your child ever had an itchy skin rash which has affected the skin creases, eg front of the elbow, behind the knees, the front of the ankles, around the neck, or around the eyes?" 
| Total IgE analysis
Total IgE levels were measured using a commercially available ELISA kit (Omega diagnostic, UK), according to the manufacturer's instructions. The optical densities (ODs) of the standards, positive control and samples were measured using a microplate reader at 450 nm.
The study cohort. The Butajira birth cohort from enrollment to 6.5-year follows up visits.
Elevated IgE levels were determined based on the manufacturer's recommended threshold by age range. For this study, total IgE levels greater than 144 IU/mL for age 5-10 were considered as the cut-off value to define atopy.
| Outcome definition
Atopy was defined in this study as an elevated total serum IgE. A total serum IgE concentration of ≤144 IU/mL for children aged 5-10 years was considered to be normal based on reference ranges provided by the manufacturer's recommended threshold by age range.
"Any allergic condition" was defined as a positive response to one or more of the questions on asthma, hayfever and eczema in the past 12 months, at years 6.5 follow-up.
| Statistical analysis
Data were double entered into EpiData 3.1 (EpiData, Denmark). The datasets were cleaned, coded and merged ready for analysis using Stata 12 (Statacorp, College Station, TX).
Prior to investigating the association between H. pylori infection and atopy, univariate analyses were used to identify the possible confounders. Variables that were associated with both exposure and outcome variables in the crude analysis using statistical significance at P-value < .2 were considered to be possible confounders. Additionally, we included variables previously shown to be associated with atopy and/or elevated total IgE in the literature; child's sex, 45 smoking, 46 antibiotic use 47 and intestinal parasite status. 48 We estimated odds ratios (ORs) associated with H. pylori positivity for atopy and "any allergic condition" using multivariate logistic regression. The ORs were adjusted for a priori and potential confounders listed in Table S1 . The same approach was used in a separate set of analyses to assess the effect of CagA H. pylori strain infection on atopy and self-reported allergic symptoms for all available children at year 6.5, by creating a new exposure variable with categories representing different combinations of H. pylori and Cag A exposure status: "Negative" (negative for both H. pylori and CagA strain), "H. pylori positive and CagA Negative" (positive for H. pylori but negative for Cag A strain) and "H. pylori positive and
CagA positive" (positive for both H. pylori and CagA strain). At age 6.5-year follow-up visit, the prevalence of self-reported allergy symptoms was low, ranging from 0.5% for eczema and hayfever to 2.2% for wheeze, we therefore create a new outcome variable "Any allergic condition at age 6.5" (ie positive response either to wheeze, or eczema, or hayfever in the past 12 months, at years 6.5 follow-up).
For longitudinal analysis of incident atopy between ages 3 and 6.5, those children without atopy (defined as "negative to any skin sensitization test" (SPT), ie skin prick test to either Dermatophagoides pteronyssinus or cockroach allergen <3 mm diameter) at age 3 were selected for analysis and incident atopy defined as a raised total serum IgE level at the year 6.5 follow-up. Furthermore, children with self-reported allergic symptoms such as wheeze, eczema and hayfever at ages 3 (positive response to wheeze, eczema and hayfever in the past 12 months, at years 3 and ever at year 3) were excluded for analysis of incident atopy at the year 6.5 follow-up.
Covariates were kept in the model if they changed the coefficient of exposure (H. pylori infection) by >10% or if they were independently associated with the outcome at P < .10. Probability values <.05 were considered statistically significant for main effects.
Sensitivity analysis was performed to compare the distribution of demographic and life style variables between study subject who have complete outcome data (ie "complete-case") and the "all respondents" populations. Selected early life characteristics at 2 months and 1 year of age showed that 57.5% had been vaccinated at 2 months, and only 11.7
| Ethical approval
(99 of 848) had received vitamin A supplementation at 1 year (Table S1 ).
Comparing the distribution of demographic and life style variables between all study subjects and those who have complete outcome data (ie "all respondents" and "complete-case"), found similar distribution patterns in relation to demographic and life style characteristics (Table S2 ).
3.3 | Prevalence of atopy and allergic conditions among children followed up at age 6.5
The prevalence of atopy among children enrolled at the 6.5-year follow-up visit was 18.1% (129 of 713), with a higher proportion among rural (20.0%) than urban (6.1%) residents, P < .05 (Table 2) .
Using an ISAAC core allergy and environmental questionnaire, wheezing was reported in 2.2% (18 of 806) of children whilst eczema and hayfever were reported in less than 1% of the children (Table 1) . When any combination allergic condition considered, the prevalence reached 3.0% (24 of 806), with a similar proportion among urban and rural children, (3.1% vs 3.0% in urban and rural, respectively, P = .93, Table 1 ).
| Potential confounders of atopy
The main outcome variable showed no statistically significant associ- (Table S3) .
3.5 | Association between H. pylori infection and atopy or allergic conditions at age 6.5
The prevalence of atopy was lower in children currently infected with H. pylori (15.2%) than in those not infected (18.6%), but this did not achieve statistical significance (P = 0.46). In multivariate analysis adjusted for a priori confounders, H. pylori infection at age 6.5 was inversely, though not significantly, related to prevalence of atopy and "any allergic condition" at age 6.5 years (adjusted OR, 95% CI, 0.87; 0.45-1.70, P = .69). When the analysis was restricted to those children who had H. pylori infection at age 3, 5 and 6.5 years, or those who were ever infected up to age 6.5, a more pronounced reduction in odds of atopy and "any allergic condition" was demon- Table 4) .
A broadly similar pattern, but non-significant inverse association was also observed between exposure to CagA+ H. pylori and any combination of self-reported allergic symptoms ("any allergic condition") at age 6.5 (Adjusted OR = 0.73, 95% CI, 0.10-5.56, P = .76) ( Table 5) . Crude odds ratio (OR) was calculated using binary logistic regression.
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| 1303 3.7 | Effects of H. pylori infection on incidence of atopy between ages 3 and 6.5: longitudinal analysis Table 6 presents the models for the longitudinal analysis between H. pylori infection and atopy. Data are presented for the population without atopy (defined as "negative to any skin sensitization test"
[SPT]) at age 3 to examine the effect of H. pylori infection at age 3 on the new onset of atopy (defined as raised total serum IgE level) at age 6.5. Helicobacter pylori infection at age 3 was inversely associated with incident atopy, after control for a priori and identified confounders (adjusted OR, 95% CI, 0.49; 0.27-0.89, P = .02) ( Table 6 ). Adjustment for other potential confounders did not materially change the odds ratio.
| DISCUSSION
This study provides further evidence from a low-income, populationbased birth cohort that current H. pylori infection at age 6.5 is inversely, though not significantly, related to prevalence of atopy (defined as a raised total IgE level). Any previous exposure to H. pylori infection up to age 6.5 was significantly associated with a 46% decreased odds of atopy. We also explored the effects of CagA+ strains of H. pylori infection for the first time in this cohort at the age 6.5-year follow-up visit. Infection with a CagA+ H. pylori strain was associated with a 65% decreased risk of atopy, and reached borderline statistical significance. In longitudinal analyses, infection with H. pylori at T A B L E 2 Associations between atopy at age 6.5 y and Helicobacter pylori exposures from age 3 to 6.5 y, Butajira birth-cohort study, Ethiopia. Cross-sectional analysis (N = 713) Any allergic condition' was defined as a positive response to one or more of asthma, hayfever and eczema in the past 12 mo, at years 6.5 follow-up. Exposure to H. pylori infection at any age from 3 to 6.5 y. c H. pylori positive at both time-points (3.5 and 6.5 y of age).
d
Adjusted for area of residence, maternal education and household size using multiple logistic regression analysis.
*
Reduced numbers as H. pylori measured on subsample only at age 3.
age 3 was associated with a 51% decreased risk of incident atopy at age 6.5 years.
We do not think that our findings result from selection bias for several reasons. First, the study cohort maintained high follow-up
proportions throughout the entire study period: 85.1% of the original cohort at birth, and 99.3% of those available at year 5 provided data at subsequent follow-up. Second, children who had IgE measurement results did not differ with regard to environmental, demographic and life style variables from those who had no IgE measurements. We also used a highly sensitive and specific H. pylori stool antigen test. 49 In addition, the key outcome (atopy) was defined using age-specific total IgE cut-offs, although the sensitivity and specificity of serum total IgE determination still remain controversial. 50, 51 With normal values differing in their range, an upper limit of 144 IU/mL for total IgE levels in children is generally accepted to distinguish atopics from non-atopics. 51 The role of total IgE as a biomarker for atopy and allergic disease has been suggested in several studies. 39, [51] [52] [53] Two cross-sectional studies by Burrows et al. 39 and Sunyer et al., 52 reported an independent effect of total IgE on asthma using the data from Tucson and Adjusted for place of residence, history of maternal allergy and number of older sibling, using multivariate logistic regression analysis.
T A B L E 5 Associations between allergic conditions at age 6.5 y and CagA Helicobacter pylori exposure at 6.5 y, Butajira birth-cohort study, Ethiopia. Cross-sectional analysis (N = 799) Adjusted for sex, place of residence, number of older siblings and, history of maternal and paternal allergy, using multivariate logistic regression analysis.
T A B L E 6 Models for longitudinal association between atopy at age 6.5 and exposure to Helicobacter pylori infection at age 3 y, Butajira birth-cohort study, Ethiopia (N = 444) 54 and chronic inflammatory bowel diseases. 55 Even though these conditions remain a possibility, in this cohort, all study participants were apparently healthy children, and the magnitude of intestinal parasitosis was reported very low at age 3. 17 This suggests the role of intestinal parasites in modulating the immune system and increasing serum IgE levels is likely to be low in this study cohort.
In this study, the exposure variable representing current H. pylori infection (being positive for stool antigen test) at age 6.5 was inversely, though not significantly, related to prevalence of atopy (defined as raised total IgE level). Any previous exposure up to age 6.5 (suggestive of early age exposure) was significantly associated with a 46% decreased risk of atopy (defined as raised total IgE level). Other studies have also shown no cross-sectional associations between H. pylori infection and raised total IgE among older children (age of 7.1-15.0 years) in Finland, 56 and in young adults in Germany and Spain 57 ; the latter study reported a similar magnitude of effect estimate as our study (OR = 0.88, vs 0.87 in the current study). 57 Failure to detect a significant protective effect of infections on the risk of atopy and allergic disease at age 6.5 might be related to the age of the population being studied and/or the time of infection. Early life infection is considered to have a stronger protective effect due to the fact that programming of Th cell memory against allergens commonly occurs during early childhood 58 ; the critical time period during which immunomodulation with long-lasting effects is considered most successful, probably even within the first 2 years of life. 59 Thus, infections occurring later in childhood may have shifted risk estimates towards no effect among the children studied, that is, could have masked potentially protective effects. A study in Japan reported strong inverse associations between H. pylori infection and serum IgE level in younger than older adults. 60 Similar patterns of significant inverse associations between any previous H. pylori infection up to age 6.5, but not at age 6.5, with an outcome variable "any allergic condition" (defined as a positive response to one or more of asthma, hayfever and eczema) also fit with previous observations from a large population-based study in The findings of this study must, however, be interpreted with caution. Although the atopy outcome was measured objectively using serum IgE, measures of wheeze, eczema, hayfever and asthma were based on maternal questionnaire reporting, and hence are susceptible to misclassification and recall bias. The questionnaire was based on the widely used and validated ISAAC symptoms questionnaire 44 that has been successfully used in previous studies in adults in Butajira, 61 in under-five children 62, 63 and in older age groups in Jimma, Ethiopia, 8, 64 increasing the validity of our findings.
This study also provides a borderline significant inverse association between colonization with H. pylori CagA+ strains and atopy (defined as raised total IgE) at age 6.5 (Adjusted OR = 0.35, 95% CI, 0.12-1.01, P = .051). Most of the available observational studies did not investigate the role of CagA strains on allergic disorders in general, and on atopy (defined as raised total IgE) in particular. Only one study from the US National Health and Nutrition Examination Survey 23 reported an inverse association between colonization with H. pylori CagA+ strains and skin sensitization to pollen and moulds (as measured by SPT). Although it may be difficult to compare the current finding due to the difference in outcome measurements (Total IgE vs SPT to specific allergens), previous studies indicated a good correlation between an elevated total IgE and SPT in predicting atopy in children. 65, 66 Comparing SPT to total serum IgE levels, Fajraoui et al. 67 found that the two tests agree in 80% of cases. Matricardi et al. 68 followed total and allergen-specific IgE levels in children from birth to 13 years of age. This study revealed that the evolution of total IgE was extremely heterogeneous but was parallel with that of allergen-specific IgE from the age of 5 onwards.
The hypothesis that more virulent CagA+ strains of H. pylori may have a stronger protective effects against asthma and allergic diseases has been reported in a few epidemiological and animal studies. 23, 24, 26 Although we found a borderline significant association in our study, the magnitude and direction of observed effect estimate were in the expected pattern, and our analyses were limited by insufficient statistical power as a result of the low prevalence of H. pylori infection at age 6.5 years. The low prevalence of H. pylori infection at the age of 6.5 follow-up visit in this cohort may be linked to spontaneous elimination of the bacterium, 69 or better attention to health issues in older children, or use of antibiotics for other common diseases. 70 Further study is warranted to understand the exact reason of declining H. pylori prevalence in older children in Ethiopia.
In conclusion, our study among young children from a lowincome birth cohort provides further evidence that any exposure of H. pylori up to age of 6.5 years, suggestive of early colonization, is inversely associated with atopy and any allergic condition. A modest inverse association with atopy was observed among children infected with the more virulent CagA+ strains of H. pylori.
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